Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells.

Literature DB >> 3005647

Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells.

A R Hayward, O Pontesilli, M Herberger, M Laszlo, M Levin.

Abstract

Epstein-Barr virus-transformed human B cells expressed cell surface varicella-zoster virus (VZV) antigens after superinfection with VZV although they did not form infectious centers in a plaque assay. The VZV-superinfected cells were lysed by autologous VZV-stimulated T-cell lines and their derivative clones. The effector cells were specific for VZV and an HLA DR antigen and were T4+. The specificity of lysis of Epstein-Barr virus-transformed, VZV-superinfected targets by prestimulated mononuclear cells in this system contrasted with the unrestricted lysis seen when the targets were VZV-infected fibroblasts.

Entities: Species

Mesh：

Substances：
Antigens, Viral

Year: 1986 PMID： 3005647 PMCID： PMC252891

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

16 in total

1. Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein.

Authors: C M Edson; B A Hosler; R A Respess; D J Waters; D A Thorley-Lawson
Journal: J Virol Date: 1985-10 Impact factor: 5.103

2. Long term growth in vitro of human T cell blasts with maintenance of specificity and function.

Authors: J T Kurnick; K O Grönvik; A K Kimura; J B Lindblom; V T Skoog; O Sjöberg; H Wigzell
Journal: J Immunol Date: 1979-04 Impact factor: 5.422

3. Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins.

Authors: S C Meuer; J C Hodgdon; D A Cooper; R E Hussey; K A Fitzgerald; S F Schlossman; E L Reinherz
Journal: J Immunol Date: 1983-07 Impact factor: 5.422

4. Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus.

Authors: C Kintner; B Sugden
Journal: Nature Date: 1981-12-03 Impact factor: 49.962

5. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.

Authors: E Chu; D Umetsu; M Lareau; E Schneeberger; R S Geha
Journal: Eur J Immunol Date: 1984-04 Impact factor: 5.532

6. Selective decline in cellular immune response to varicella-zoster in the elderly.

Authors: A E Miller
Journal: Neurology Date: 1980-06 Impact factor: 9.910

7. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors: G Miller; M Lipman
Journal: Proc Natl Acad Sci U S A Date: 1973-01 Impact factor: 11.205

8. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged.

Authors: R Berger; G Florent; M Just
Journal: Infect Immun Date: 1981-04 Impact factor: 3.441

9. Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens.

Authors: J A Zaia; P L Leary; M J Levin
Journal: Infect Immun Date: 1978-06 Impact factor: 3.441

10. Dw/LD-related molecular polymorphism of DR4 beta-chains.

Authors: J P Groner; A J Watson; F H Bach
Journal: J Exp Med Date: 1983-05-01 Impact factor: 14.307

15 in total

1. Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood.

Authors: J K Hickling; L K Borysiewicz; J G Sissons
Journal: J Virol Date: 1987-11 Impact factor: 5.103

Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells.

1. Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein.

2. Long term growth in vitro of human T cell blasts with maintenance of specificity and function.

3. Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins.

4. Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus.

5. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.

6. Selective decline in cellular immune response to varicella-zoster in the elderly.

7. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

8. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged.

9. Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens.

10. Dw/LD-related molecular polymorphism of DR4 beta-chains.

1. Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood.

2. Processing and presentation of cell-associated varicella-zoster virus antigens by human monocytes.

3. Modulation of major histocompatibility class II protein expression by varicella-zoster virus.

4. Persistent detection of varicella-zoster virus DNA in a previously healthy child after severe chickenpox.

5. Demonstration of MHC class II-restricted cytotoxic T lymphocytes in mice against herpes simplex virus.

6. Lymphocyte responses to varicella zoster virus in the elderly.

Review 7. T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

8. Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs.

9. Establishment and functional characterization of human herpesvirus 6-specific CD4+ human T-cell clones.

10. Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4+ human T-cell clones.